These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 23826859)

  • 1. In vitro and in vivo influence of penetration enhancers in the topical application of celecoxib.
    Quiñones OG; Mata dos Santos HA; Kibwila DM; Leitão A; dos Santos Pyrrho A; Pádula Md; Rosas EC; Lara MG; Pierre MB
    Drug Dev Ind Pharm; 2014 Sep; 40(9):1180-9. PubMed ID: 23826859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro and In Vivo Evaluation of DMSO and Azone as Penetration Enhancers for Cutaneous Application of Celecoxib.
    Senna TD; Mata Dos Santos HA; Kibwila DM; Leitao AC; Santos Pyrrho AD; de Padula M; Rosas EC; Padua TA; Lara MG; Riemma Pierre MB
    Curr Drug Deliv; 2017; 14(7):992-1004. PubMed ID: 28124617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid Crystalline Systems Based on Glyceryl Monooleate and Penetration Enhancers for Skin Delivery of Celecoxib: Characterization, In Vitro Drug Release, and In Vivo Studies.
    Dante MCL; Borgheti-Cardoso LN; Fantini MCA; Praça FSG; Medina WSG; Pierre MBR; Lara MG
    J Pharm Sci; 2018 Mar; 107(3):870-878. PubMed ID: 29108729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copaiba oil enhances in vitro/in vivo cutaneous permeability and in vivo anti-inflammatory effect of celecoxib.
    Quiñones OG; Hossy BH; Padua TA; Miguel NCO; Rosas EC; Ramos MFS; Pierre MBR
    J Pharm Pharmacol; 2018 Jul; 70(7):964-975. PubMed ID: 29600536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid crystalline systems for transdermal delivery of celecoxib: in vitro drug release and skin permeation studies.
    Estracanholli EA; Praça FS; Cintra AB; Pierre MB; Lara MG
    AAPS PharmSciTech; 2014 Dec; 15(6):1468-75. PubMed ID: 24980082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced in vitro percutaneous absorption and in vivo anti-inflammatory effect of a selective cyclooxygenase inhibitor using microemulsion.
    Subramanian N; Ghosal SK; Moulik SP
    Drug Dev Ind Pharm; 2005 May; 31(4-5):405-16. PubMed ID: 16093206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin.
    Steluti R; De Rosa FS; Collett J; Tedesco AC; Bentley MV
    Eur J Pharm Biopharm; 2005 Aug; 60(3):439-44. PubMed ID: 15996585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretreatment with skin permeability enhancers: importance of duration and composition on the delivery of diclofenac sodium.
    Maurya A; Murthy SN
    J Pharm Sci; 2014 May; 103(5):1497-503. PubMed ID: 24644068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical delivery of celecoxib using microemulsion.
    Subramanian N; Ghosal SK; Moulik SP
    Acta Pol Pharm; 2004; 61(5):335-41. PubMed ID: 15747689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Copaiba Oil: Chemical Composition and Influence on In-vitro Cutaneous Permeability of Celecoxib.
    Quinones OG; Abranches RP; Nakamura MJ; de Souza Ramos MF; Riemma Pierre MB
    Curr Drug Deliv; 2018; 15(3):357-366. PubMed ID: 28847273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of non-phospholipid-based cationic and phospholipid-based anionic nanosized emulsions on skin retention and anti-inflammatory activity of celecoxib.
    Tamilvanan S; Baskar R
    Pharm Dev Technol; 2013; 18(4):761-71. PubMed ID: 23668371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations.
    Shamsher AA; Charoo NA; Rahman Z; Pillai KK; Kohli K
    Pharm Dev Technol; 2014 Feb; 19(1):21-30. PubMed ID: 23281713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation.
    Moreira TS; de Sousa VP; Pierre MB
    AAPS PharmSciTech; 2010 Jun; 11(2):621-9. PubMed ID: 20373151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and evaluation of transdermal patches of celecoxib.
    Alam MI; Baboota S; Kohli K; Ali J; Ahuja A
    PDA J Pharm Sci Technol; 2009; 63(5):429-37. PubMed ID: 20158049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib.
    Baboota S; Shakeel F; Ahuja A; Ali J; Shafiq S
    Acta Pharm; 2007 Sep; 57(3):315-32. PubMed ID: 17878111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the topical delivery of zinc phthalocyanine using oleic acid as a penetration enhancer: in vitro permeation and retention.
    da Silva ER; de Freitas ZM; Gitirana Lde B; Ricci-Júnior E
    Drug Dev Ind Pharm; 2011 May; 37(5):569-75. PubMed ID: 21128702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ intestinal permeability and in vivo oral bioavailability of celecoxib in supersaturating self-emulsifying drug delivery system.
    Song WH; Yeom DW; Lee DH; Lee KM; Yoo HJ; Chae BR; Song SH; Choi YW
    Arch Pharm Res; 2014 May; 37(5):626-35. PubMed ID: 23852645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro permeation of carvedilol through porcine skin: effect of vehicles and penetration enhancers.
    Gannu R; Vishnu YV; Kishan V; Rao YM
    PDA J Pharm Sci Technol; 2008; 62(4):256-63. PubMed ID: 19174954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.
    Pinheiro VA; Serikaku D; Baby AR; Velasco MV; Kaneko TM; Consiglieri VO
    Pharm Dev Technol; 2015 Mar; 20(2):197-203. PubMed ID: 24286179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of liposomes, transfersomes and ethosomes as carriers for improving topical delivery of celecoxib.
    Bragagni M; Mennini N; Maestrelli F; Cirri M; Mura P
    Drug Deliv; 2012; 19(7):354-61. PubMed ID: 23043648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.